Indication
High-risk
17 clinical trials
28 products
4 drugs
Clinical trial
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their OffspringStatus: Recruiting, Estimated PCD: 2033-05-01
Product
RelugolixClinical trial
MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination TherapyStatus: Not yet recruiting, Estimated PCD: 2027-05-01
Clinical trial
DECIDE: A Comparative Effectiveness Trial of Oral Metformin Versus Injectable Insulin for the Treatment of Gestational DiabetesStatus: Not yet recruiting, Estimated PCD: 2029-12-01
Drug
MetforminProduct
InsulinClinical trial
A Single-arm Prospective Study of the Treatment in High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease DetectionStatus: Not yet recruiting, Estimated PCD: 2027-09-01
Drug
CarfilzomibProduct
DaratumumabProduct
LenalidomideProduct
DexamethasoneProduct
VRDClinical trial
Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational DiabetesStatus: Recruiting, Estimated PCD: 2024-10-01
Product
Patient-led InsulinProduct
Provider-led InsulinClinical trial
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes (Close the GAP)Status: Recruiting, Estimated PCD: 2025-10-31
Product
Sliding Scale InsulinProduct
Home InsulinProduct
Continuous Insulin InfusionClinical trial
Comparison of 68 Ga-PSMA Positron Emission Tomography (PET)/CT to Conventional Imaging in Men With High Risk Prostate CancerStatus: Completed, Estimated PCD: 2022-02-26
Product
68Ga-PSMAClinical trial
Safety, Efficacy, Pharmacokinetics, and Pharmacogenomics of Extended-Release Naltrexone in Pregnant WomenStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Improvement of PPROM Management With Prophylactic Antimicrobial TherapyStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Product
CeftriaxoneProduct
ClarithromycinProduct
MetronidazoleProduct
AmpicillinProduct
AmoxicillinProduct
AzithromycinProduct
ErythromycinClinical trial
Using the Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy: A Randomized Controlled Trial (The Patch BRIDGE Trial)Status: Recruiting, Estimated PCD: 2025-12-31
Product
BuprenorphineClinical trial
A Randomised Controlled Trial to Assess the Pharmacokinetics and Pharmacodynamics of Intramuscular, Intravenous and Oral Administration of Tranexamic Acid in Women Giving Birth by Caesarean SectionStatus: Completed, Estimated PCD: 2021-06-30
Product
Tranexamic AcidClinical trial
Lenalidomide, Bortezomib, and Dexamethasone Combination Therapy as Induction Followed by Bortezomib and Lenalidomide Maintenance in Patients With Newly Diagnosed High Risk Multiple MyelomaStatus: Recruiting, Estimated PCD: 2025-12-30
Drug
bortezomibDrug
lenalidomideClinical trial
General Skin and Nasal Decolonization With Octenisan® Set Be-fore and After Elective Orthopedic Surgery in Selected Patients at Elevated Risk for Revision Surgery and Surgical Site InfectionsStatus: Recruiting, Estimated PCD: 2025-01-31
Product
OctenidinClinical trial
Remote Antenatal Maternal-fetal Telemedicine Monitoring in High-risk Pregnancies: a Feasibility and Acceptability StudyStatus: Not yet recruiting, Estimated PCD: 2024-08-01
Product
PulsenmoreClinical trial
Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)Status: Recruiting, Estimated PCD: 2025-12-31
Product
LovenoxClinical trial
Adjuvant Androgen Deprivation Therapy Combined With Apalutamide for Prostate Cancer Patients Post Radical-prostatectomy With High-risk of Reoccurrence: a Prospective, Single-arm, Multicenter Trial (ARES Study)Status: Not yet recruiting, Estimated PCD: 2026-08-31
Product
ApalutamideProduct
Androgen deprivation therapyClinical trial
Intravenous Insulin Versus Subcutaneous Insulin Infusion in Intrapartum Management of Pregnant Women With Type 1 Diabetes Mellitus: A Randomized TrialStatus: Completed, Estimated PCD: 2023-05-01